HPV testing for cervical cancer screening: technical improvement of laboratory logistics and good clinical performance of the cobas 6800 in comparison to the 4800 system

The cobas® 6800/8800 System: a new era of automation in molecular diagnostics

(2017) Bryan Cobb et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice

(2017) Nicolas Wentzensen et al.   INTERNATIONAL JOURNAL OF CANCER

Multicenter Comparison Study of both Analytical and Clinical Performance across Four Roche Hepatitis C Virus RNA Assays Utilizing Different Platforms

(2017) Johannes Vermehren et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Optimal Management Strategies for Primary HPV Testing for Cervical Screening: Cost-Effectiveness Evaluation for the National Cervical Screening Program in Australia

(2017) Kate T. Simms et al.   PLoS One

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study

(2016) Birgit Engesæter et al.   BMC INFECTIOUS DISEASES

Management of high-risk HPV-positive women for detection of cervical (pre)cancer

(2016) Roosmarijn Luttmer et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Workflow and Maintenance Characteristics of Five Automated Laboratory Instruments for the Diagnosis of Sexually Transmitted Infections

(2014) S. Ratnam et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women

(2014) Annarosa Del Mistro et al.   JOURNAL OF MEDICAL SCREENING

Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study

(2013) M Zorzi et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

HPV Testing by cobas HPV Test in a Population from Catalonia

(2013) Belén Lloveras et al.   PLoS One

A Long-term Prospective Study of Type-Specific Human Papillomavirus Infection and Risk of Cervical Neoplasia Among 20,000 Women in the Portland Kaiser Cohort Study

(2011) M. Schiffman et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening

(2011) Dorien C. Rijkaart et al.   INTERNATIONAL JOURNAL OF CANCER

Clinical Validation of the cobas 4800 HPV Test for Cervical Screening Purposes

(2011) D. A. M. Heideman et al.   JOURNAL OF CLINICAL MICROBIOLOGY

A review of human carcinogens—Part B: biological agents

(2009) Véronique Bouvard et al.   LANCET ONCOLOGY

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER